Experience

• 

  Berkeley Lights, Inc.

  • San Francisco Bay Area /Chicago

  • Vice President Business Development

    • Nov 2015 - Feb 2017
    • San Francisco Bay Area /Chicago

    Leading the adoption, use and commercialization of BLI's breakthrough systems utilizing proprietary OptoSelect nanofluidic light technology that enables the massively parallel single cell sorting, selection, annotation, assaying, culturing and library preparation for sequencing. BLI is positioned to transform cancer genomics, T-Cell therapy (TIL, PBMC, CAR-T, Gene-edited) and biopharma discovery.

• 

  Cepheid

  • Sunnyvale, CA

  • Sr. Director, Strategic Oncology Market Development

    • Mar 2013 - Nov 2015
    • Sunnyvale, CA

    Reporting directly to the CEO of Cepheid, this prominent leadership position partners with the Oncology Program Team and Executive Team in developing and executing business strategies to increase shareholder value in the area of cancer diagnostics. The position is focused on global analysis and key strategic guidance that results in the development of a pipeline of products in the area of solid tumor and hematological malignancies. The position leverages market research and clinical management insights which manifest themselves into disruptive technology products on Cepheid’s system platforms. Consultant to Cepheid March 2013 - March 2014.

• 

  Koska & Associates, LLC

  • Greater Chicago Area

  • Senior Consultant

    • 2011 - 2013
    • Greater Chicago Area

    Provide experiential consulting to key clients in the molecular diagnostic industry on overall corporate strategy and technology applications; product conceptualization and strategy; product positioning and marketing; and sales deployment and training. Areas of expertise include molecular oncology, infectious disease, genetics, personalized medicine and pharmacogenomics. Client list includes many leaders in the molecular diagnostic space.

• 

  Cepheid

  • United States
  • Biotechnology Research
  • 700 & Above Employee

  • Sr. VP US Sales Operations

    • 2009 - 2011

    Trained, developed, and motivated staff in multidisciplinary sales approach focused on institutional financial and individual patient benefits. Established industry-leading sales growth far exceeding secular trends via customer expansion and customer retention by creating penetration and competitive immunity programs including clinical outcome-based account business reviews.

  • Sr. Vice President WW Commercial Operations

    • 2005 - 2009

    Partnered with CEO in creating and implementing business strategies to increase shareholder value. Designed and annually updated 5-year strategic plan encompassing market analysis assay portfolio identification, instrument service model, and long-term revenues for clinical, industrial, and biothreat markets. Led up to 110 sales, marketing, technical service, customer service, and instrument service staff operating in North American, European, and ROW marketplace. Represented the company at numerous investor and analyst conferences. Corporate Officer and member of the senior management team that raised $86MM as part of a secondary offerring.

• 

  Abbott Molecular

  • Greater Chicago Area

  • Divisonal VP North American Sales Abbott Molecular-U.S and Canadian Sales

    • 2001 - 2005
    • Greater Chicago Area

    Leveraged nine-year company tenure to direct 50 sales and technical staff for market leader in development and commercialization of DNA technology products for pathology, solid tumor oncology, hematology/oncology, urology, clinical genetics, and research markets. Also served as DVP Worldwide Strategic Marketing and Sales for a short period directly after the Abbott acquisition of Vysis in 2001. Also served as DVP Strategic Marketing-Vysis at Abbott Molecular during this tenure.

• 

  Vysis

  • Greater Chicago Area

  • Senior Vice President of Worldwide Sales and Marketing

    • 1996 - 2001
    • Greater Chicago Area

    Collaborated with CEO in designing and implementing business strategies to increase shareholder value in role as a Corporate Officer. Introduced novel technology and industry leading products in the prenatal genetics, breast cancer, hematology/oncolgy and urology areas of in vitro diagnostics. Corporate Officer and member of the senior management team that sold Vysis to Abbott Laboratories for $355MM.

• 

  DIFCO LABORATORIES

  • Eastern Area Sales Manager

    • 1988 - 1996

• 

  Additional Experience

  • Sales and Marketing

    • 1983 - 1996

    Director of Marketing (1997 to 1999) and Marketing Manager – Cancer Diagnostics (1996 to 1997) with Vysis, Inc. as well as Eastern Area Sales Manager / Senior Product Manager / Product Manager / Associate Product Manager (1989 to 1996) with DIFCO Laboratories, Inc. and Territory Manager (1987 to 1989) with Bristol Meyers, Genetic Systems Corporation. Sales Positions with J&J-Ortho Diagnostic Systems